• Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
New Treatment for Peritoneal Cancer
19 Nov 2021

Gleneagles Hospital Hong Kong’s Peritoneal Malignancy Treatment Centre has introduced new intraperitoneal chemotherapy procedures, including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC), to provide more effective treatment to patients with peritoneal cancer.

Dr Kenneth Tsang, Chief Executive Officer of Gleneagles Hospital Hong Kong, said, “In addition to our advanced radiotherapy facilities, we have also launched a centre dedicated to serving patients with peritoneal metastasis. Our experienced multidisciplinary medical team provides patients with comprehensive diagnostic services and personalised treatments.” The Centre is the first of its kind in Hong Kong catering to patients with peritoneal metastasis. Medical studies have found HIPEC to effectively improve the survival rate of patients with ovarian cancer, gastric cancer or colorectal cancer. The innovative PIPAC treatment is also known to relieve symptoms of peritoneal metastasis and reduce the side effects of chemotherapy, which helps improve the patient’s quality of life.

Topics:

Brands:

Related Stories

Mount Elizabeth’s Revitalisation Sets a New Benchmark for Patient-Centred Care in the Region

IHH Healthcare Singapore is strengthening its legacy of care through the revitalisation of Mount Elizabeth Hospital (MEH), a flagship institution that has supported patients from Singapore, Indonesia and across the region for more than 45 years.

19 Nov 2021
Read More

Fortis Charts the Future of Haematology

On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.

19 Nov 2021
Read More

Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation

IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.

19 Nov 2021
Read More

Parkway Shanghai Hospital and Shanghai General Hospital Establish Strategic Partnership to Advance High-Quality Healthcare

Parkway Shanghai Hospital and Shanghai General Hospital have formalised a strategic cooperation agreement to jointly develop innovative models of integrated healthcare that unite international expertise with local strengths.
19 Nov 2021
Read More

Fortis Launches Adayu, a Hospital Dedicated to Specialised Mental Health Care

Fortis marked an important milestone with the launch of Adayu, a dedicated mental health facility designed to deliver compassionate, evidence based, and personalised care for individuals seeking renewed wellbeing.
19 Nov 2021
Read More

Strengthening Our Care Continuum in Shanghai

The Grand Opening of Parkway MediCentre Xintiandi reflects IHH’s long-term commitment to China and marks a major milestone in our transformational out-of-hospital strategy.
19 Nov 2021
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Parkway Radiology Logo
  • Acibadem Labmed Logo
  • Parkway Laboratories Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo